-
1.发明申请公开(公告)号：US20220298236A1
公开(公告)日：2022-09-22
申请号：US17691182
申请日：2022-03-10
Applicant: Janssen Biotech, Inc.
Inventor： Elizabeth Hsia , Alexa Kollmeier , Xie Ku
Abstract: A method of treating psoriatic arthritis in a patient by administering an IL-23 specific antibody, e.g., guselkumab, in a clinically proven safe and clinically proven effective amount and the patient achieves significant ACR20/50/70, IGA, HAQ-DI, CRP, SF-36 PCS/MCS, MDA, VLDA, enthesitis, dactylitis, and LEI/dactylitis improvement as measured 16, 24, 52, and/or 100 weeks after initial treatment.
Search Results
1
records
(took 0.01 seconds)
筛选
AND
AND
过滤
NOT
NOT
Scan to Join
